Frontlight ResearchEarly access
Taking peoplePhase 1
Tests CLN-978 in adults with rheumatoid arthritis that treatments have not controlled
Tests CLN-978 in adults with rheumatoid arthritis that has not responded to prior treatment.
Key facts
- Who runs it
- Cullinan Therapeutics Inc.
- Where
- Cracow, Poznan, Warsaw, and Zyrardow, PolandSee the 4 sitesAlso in 2 other countries, 5 sites
- Trial code
- Registry title
- A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 85 people, planned
- Started
- 15 May 2025
- Expected to end
- 1 Nov 2030
- Type of study
- Interventional
- Record updated
- 13 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rheumatoid arthritis that has not responded to treatment.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Rheumatoid arthritis that has not responded to treatment (treatment-refractory).
Where in Poland
Also in 2 other countries, 5 sites
- Malopolskie Centrum KliniczneCracow, PolandNot yet recruiting
- Med Polonia Sp z o.o.Poznan, PolandNot yet recruiting
- Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory ReicherWarsaw, PolandNot yet recruiting
- Centrum Zdrowia Mazowsza Zachodniego Sp. z o.o.Zyrardow, PolandNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Tests CLN-978 in adults with rheumatoid arthritis that treatments have not controlledGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 13 November 2026